Paclitaxel Treatment Options

A collection of 2016 research studies where Paclitaxel is the interventional treatment. These studies are located in the United States. Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.

Home

All Treatments

Paclitaxel

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer

NCT00702299

Completed

RATIONALE: Pemetrexed may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as cisplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving pemetrexed together with cisplatin and paclitaxel and giving them in different ways may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of intraperito... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

12/02/2015

Locations: Arizona Oncology - Scottsdale, Scottsdale, Arizona +1 locations

Conditions: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer

Learn More ›

Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation

NCT00861627

Completed

The purpose of this Phase 2 study is to investigate whether intravenous administration of a wild type reovirus (REOLYSIN®) in combination with paclitaxel and carboplatin is effective and safe in the treatment of Non-Small Cell Lung Cancer with KRAS or EGFR activation.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/01/2015

Locations: Georgetown University Medical Center, Washington, District of Columbia +1 locations

Conditions: Carcinoma, Non-small Cell Lung

Learn More ›

Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma

NCT00568451

Terminated

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether giving paclitaxel together with carboplatin is more effective than giving temozolomide alone in treating patients with melanoma. PURPOSE: This phase II trial is studying the side effects and how well giving paclitaxel together with carboplatin or giving temozolomide alone works in treating patients with stage I... Read More

Gender:

ALL

Ages:

Between 18 years and 120 years

Trial Updated:

11/25/2015

Locations: Mayo Clinic Cancer Center, Rochester, Minnesota

Conditions: Melanoma (Skin)

Learn More ›

Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver

NCT00833807

Completed

The goal of this clinical research is to find the highest tolerable dose of Abraxane (nab-paclitaxel) when given directly to the area where the cancer is located. The safety of this drug will also be studied.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/25/2015

Locations: University of Texas MD Anderson Cancer Center, Houston, Texas

Conditions: Melanoma, Liver Metastasis

Learn More ›

Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment

NCT00807573

Completed

The purpose of this study is to determine the percentage of patients with non-small cell lung cancer that will experience a shrinkage of their tumors following treatment with three medications given together: paclitaxel, pemetrexed (Alimta®), and bevacizumab (Avastin®). Each of these medications has been approved by the FDA for patients that have not received any treatment for their lung cancer. This study is designed to study the effects of all three drugs given at the same time. Each of these... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/24/2015

Locations: Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey +4 locations

Conditions: Lung Cancer

Learn More ›

Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

NCT00426556

Completed

Phase I: will look at different dose levels and regimens of everolimus combined with weekly trastuzumab and paclitaxel therapy in patients with HER-2 overexpressing metastatic breast cancer. Phase II: will assess the efficacy and safety of the 10mg daily dose of everolimus combined with weekly trastuzumab and paclitaxel therapy in patients with HER-2 overexpressing metastatic breast cancer.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/24/2015

Locations: Wilshire Oncology Medical Group La Verne, *see Various Departments*, California +19 locations

Conditions: Metastatic Breast Cancer

Learn More ›

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

NCT00112294

Completed

The primary purpose of this clinical research study is to learn if patients treated with the combination of Taxane/Carboplatin plus Cetuximab (C/T/C) have a longer progression-free survival than patients treated with Taxane/Carboplatin (T/C) alone. The safety of this treatment will also be studied.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/24/2015

Locations: Local Institution, Birmingham, Alabama +124 locations

Local Institution, Birmingham, Alabama

Local Institution, Mobile, Alabama

Local Institution, Anchorage, Alaska

Local Institution, Tucson, Arizona

Local Institution, Springdale, Arkansas

Local Institution, Anaheim, California

Local Institution, Bakersfield, California

Local Institution, Concord, California

Local Institution, Fountain Valley, California

Local Institution, Gilroy, California

Local Institution, Long Beach, California

Local Institution, Los Angeles, California

Local Institution, Montebello, California

Local Institution, Oxnard, California

Local Institution, Rancho Mirage, California

Local Institution, San Diego, California

Local Institution, Stockton, California

Local Institution, Vista, California

Local Institution, Lakewood, Colorado

Local Institution, Binghamton, Connecticut

Local Institution, Hartford, Connecticut

Local Institution, New London, Connecticut

Local Institution, Norwich, Connecticut

Local Institution, Stamford, Connecticut

Local Institution, Waterbury, Connecticut

Local Institution, Washington, District of Columbia

Local Institution, Boca Raton, Florida

Local Institution, Boynton Beach, Florida

Local Institution, Fort Lauderdale, Florida

Local Institution, Fort Myers, Florida

Local Institution, Inverness, Florida

Local Institution, Jacksonville, Florida

Local Institution, Lakeland, Florida

Local Institution, Lecanto, Florida

Local Institution, Pembroke Pines, Florida

Local Institution, Port Saint Lucie, Florida

Local Institution, Tamarac, Florida

Local Institution, Tampa, Florida

Local Institution, Augusta, Georgia

Local Institution, Columbus, Georgia

Local Institution, Marietta, Georgia

Local Institution, Honolulu, Hawaii

Local Institution, Evanston, Illinois

Local Institution, Joliet, Illinois

Local Institution, Naperville, Illinois

Local Institution, Normal, Illinois

Local Institution, Skokie, Illinois

Local Institution, Fort Wayne, Indiana

Local Institution, Muncie, Indiana

Local Institution, New Albany, Indiana

Local Institution, Terre Haute, Indiana

Local Institution, Vincennes, Indiana

Local Institution, Wichita, Kansas

Local Institution, Hazard, Kentucky

Local Institution, Paducah, Kentucky

Local Institution, Annapolis, Maryland

Local Institution, Baltimore, Maryland

Local Institution, Westminster, Maryland

Local Institution, Boston, Massachusetts

Local Institution, Brockton, Massachusetts

Local Institution, Flint, Michigan

Local Institution, Free Soil, Michigan

Local Institution, Grand Rapids, Michigan

Local Institution, Jackson, Michigan

Local Institution, Dulluth, Minnesota

Local Institution, Minneapolis, Minnesota

Local Institution, St. Louis Park, Minnesota

Local Institution, Jackson, Mississippi

Local Institution, Columbia, Missouri

Local Institution, Jefferson City, Missouri

Local Institution, Dover, New Hampshire

Local Institution, Newark, New Jersey

Local Institution, Bronx, New York

Local Institution, Cooperstown, New York

Local Institution, New City, New York

Local Institution, New Rochelle, New York

Local Institution, Northport, New York

Local Institution, Rochester, New York

Local Institution, Valhalla, New York

Local Institution, Burlington, North Carolina

Local Institution, Charlotte, North Carolina

Local Institution, Gastonia, North Carolina

Local Institution, Greensboro, North Carolina

Local Institution, Greenville, North Carolina

Local Institution, Hickory, North Carolina

Local Institution, Morganton, North Carolina

Local Institution, Wilmington, North Carolina

Local Institution, Winston-Salem, North Carolina

Local Institution, Bismarck, North Dakota

Local Institution, Bismark, North Dakota

Local Institution, Canton, Ohio

Local Institution, Cincinnati, Ohio

Local Institution, Cleveland, Ohio

Local Institution, Columbus, Ohio

Local Institution, Dayton, Ohio

Local Institution, Oklahoma City, Oklahoma

Local Institution, Bethlehem, Pennsylvania

Local Institution, Dunmore, Pennsylvania

Local Institution, Harrisburg, Pennsylvania

Local Institution, Philadelphia, Pennsylvania

Local Institution, Pottstown, Pennsylvania

Local Institution, Sayre, Pennsylvania

Local Institution, West Reading, Pennsylvania

Local Institution, Providence, Rhode Island

Local Institution, Charleston, South Carolina

Local Institution, Columbia, South Carolina

Local Institution, Mt. Pleasant, South Carolina

Local Institution, Spartanburg, South Carolina

Local Institution, Sumter, South Carolina

Local Institution, Chattanooga, Tennessee

Local Institution, Collierville, Tennessee

Local Institution, Cookeville, Tennessee

Local Institution, Amarillo, Texas

Local Institution, Dallas, Texas

Local Institution, Houston, Texas

Local Institution, Lubbock, Texas

Local Institution, Danville, Virginia

Local Institution, Lynchburg, Virginia

Local Institution, Richmond, Virginia

Local Institution, Everett, Washington

Local Institution, Lacey, Washington

Local Institution, Tacoma, Washington

Local Institution, Huntington, West Virginia

Local Institution, La Crosse, Wisconsin

Local Institution, Madison, Wisconsin

Conditions: Non-Small-Cell Lung Carcinoma

Learn More ›

Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel

NCT01332656

Completed

Primary Objective: - To demonstrate an improvement in Progression-Free Survival (PFS) for Ombrabulin versus placebo in patients with platinum-sensitive recurrent ovarian cancer (OC) treated with paclitaxel and carboplatin. Secondary Objectives: * To compare the overall survival (OS) between the 2 treatment arms * To compare the objective response rate (RR) between the 2 treatment arms

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/18/2015

Locations: Investigational Site Number 840007, Burbank, California +37 locations

Investigational Site Number 840007, Burbank, California

Investigational Site Number 840001, New Haven, Connecticut

Investigational Site Number 840202, Fort Meyers, Florida

Investigational Site Number 840009, Atlanta, Georgia

Investigational Site Number 840002, Boston, Massachusetts

Investigational Site Number 056002, Haine-Saint-Paul, Not set

Investigational Site Number 056005, Kortrijk, Not set

Investigational Site Number 056001, Leuven, Not set

Investigational Site Number 056003, Namur, Not set

Investigational Site Number 203003, Novy Jicin, Not set

Investigational Site Number 203002, Olomouc, Not set

Investigational Site Number 203001, Praha 2, Not set

Investigational Site Number 203004, Zlin, Not set

Investigational Site Number 250006, Bordeaux, Not set

Investigational Site Number 250004, Caen Cedex 05, Not set

Investigational Site Number 250001, Lyon, Not set

Investigational Site Number 250002, Paris Cedex 4, Not set

Investigational Site Number 250003, Villejuif, Not set

Investigational Site Number 276001, München, Not set

Investigational Site Number 380004, Genova, Not set

Investigational Site Number 380003, Milano, Not set

Investigational Site Number 380001, Roma, Not set

Investigational Site Number 616002, Krakow, Not set

Investigational Site Number 616004, Poznan, Not set

Investigational Site Number 616003, Rybnik, Not set

Investigational Site Number 616005, Warszawa, Not set

Investigational Site Number 616001, Warszawa, Not set

Investigational Site Number 643002, Moscow, Not set

Investigational Site Number 643003, Moscow, Not set

Investigational Site Number 643001, Moscow, Not set

Investigational Site Number 643004, Saint-Petersburg, Not set

Investigational Site Number 724002, Barcelona, Not set

Investigational Site Number 724003, Madrid, Not set

Investigational Site Number 724001, Madrid, Not set

Investigational Site Number 804003, Dnipropetrovsk, Not set

Investigational Site Number 804005, Donetsk, Not set

Investigational Site Number 804004, Kharkov, Not set

Investigational Site Number 804002, Lviv, Not set

Conditions: Ovarian Cancer Recurrent

Learn More ›

HAI Abraxane With Gemcitabine and Bevacizumab

NCT01057264

Completed

The goal of this clinical research study is to find the highest tolerable dose of Abraxane® (nab-paclitaxel) when given directly into the liver, in combination with Gemzar® (gemcitabine) and Avastin® (bevacizumab) when given by vein.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/16/2015

Locations: UT MD Anderson Cancer Center, Houston, Texas

Conditions: Advanced Cancers

Learn More ›

A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer

NCT00762034

Completed

This study will compare overall survival in participants with Stage IIIB or IV nonsquamous non-small cell lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/16/2015

Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Fayetteville, Arkansas +66 locations

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Fayetteville, Arkansas

Conditions: Non-small Cell Lung Cancer

Learn More ›

Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer

NCT00005087

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors such as filgrastim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy. Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase II trial to study the effectiveness of paclitaxel, cisplatin, and filgrastim combined w... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/14/2015

Locations: University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama +234 locations

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama

Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama

Huntsville Hospital System, Huntsville, Alabama

MBCCOP - Gulf Coast, Mobile, Alabama

Alabama Oncology, LLC, Montgomery, Alabama

DCH Cancer Treatment Center, Tuscaloosa, Alabama

Foundation for Cancer Research and Education, Phoenix, Arizona

Mount Diablo Medical Center, Concord, California

City of Hope Comprehensive Cancer Center, Duarte, California

Saint Agnes Cancer Center, Fresno, California

California Cancer Center, Fresno, California

Sutter Health West Cancer Research Group, Greenbrae, California

Loma Linda University Medical Center, Loma Linda, California

Veterans Affairs Medical Center - Long Beach, Long Beach, California

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California

CCOP - Bay Area Tumor Institute, Oakland, California

Huntington Cancer Center, Pasadena, California

Robert and Beverly Lewis Family Cancer Care Center, Pomona, California

Radiation Oncology Center - Sacramento, Sacramento, California

Radiation Medical Group, Inc., San Diego, California

UCSF Comprehensive Cancer Center, San Francisco, California

O'Connor Hospital, San Jose, California

CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California

David Grant Medical Center, Travis Air Force Base, California

Memorial Hospital Cancer Center, Colorado Springs, Colorado

University of Colorado Cancer Center, Denver, Colorado

Saint Mary's Hospital and Medical Center, Grand Junction, Colorado

Hospital of St. Raphael, New Haven, Connecticut

CCOP - Christiana Care Health Services, Wilmington, Delaware

University of Florida Health Science Center, Gainesville, Florida

Florida Radiation Oncology Group, Jacksonville, Florida

Health First Holmes Regional Medical Center, Melbourne, Florida

CCOP - Mount Sinai Medical Center, Miami Beach, Florida

Veterans Affairs Medical Center - Miami, Miami, Florida

Sylvester Cancer Center, University of Miami, Miami, Florida

Baptist Hospital of Miami, Miami, Florida

MD Anderson Cancer Center Orlando, Orlando, Florida

Bay Medical Center, Panama City, Florida

Gulf Coast Cancer Treatment Center, Panama City, Florida

Sarasota Radiation and Medical Oncology Center, Sarasota, Florida

Tallahassee Memorial Healthcare, Tallahassee, Florida

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Emory University Hospital - Atlanta, Atlanta, Georgia

CCOP - Atlanta Regional, Atlanta, Georgia

Medical Center/John B. Amos Community Cancer Center, Columbus, Georgia

Regional Radiation Oncology Center at Rome, Rome, Georgia

MBCCOP - Hawaii, Honolulu, Hawaii

Northwest Community Hospital, Arlington Heights, Illinois

Northwestern Memorial Hospital, Chicago, Illinois

CCOP - Central Illinois, Decatur, Illinois

Ingalls Memorial Hospital, Harvey, Illinois

Loyola University Medical Center, Maywood, Illinois

Lutheran General Cancer Care Center, Park Ridge, Illinois

Methodist Medical Center of Illinois, Peoria, Illinois

St. John's Medical Center, Anderson, Indiana

Bloomington Hospital, Bloomington, Indiana

Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana

Clarian Health Partners Inc., Indianapolis, Indiana

Regional Cancer Center, Indianapolis, Indiana

Ball Memorial Hospital, Muncie, Indiana

CCOP - Northern Indiana CR Consortium, South Bend, Indiana

Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa

Central Baptist Hospital, Lexington, Kentucky

Albert B. Chandler Medical Center, University of Kentucky, Lexington, Kentucky

James Graham Brown Cancer Center, Louisville, Kentucky

Louisville Radiation Oncology, Louisville, Kentucky

Merle M. Mahr Cancer Center, Madisonville, Kentucky

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

Tulane University School of Medicine, New Orleans, Louisiana

MBCCOP - LSU Medical Center, New Orleans, Louisiana

CCOP - Ochsner, New Orleans, Louisiana

Maine Medical Center, Portland, Maine

Anne Arundel Oncology Center, Annapolis, Maryland

Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland

Greater Baltimore Medical Center and Cancer Center, Baltimore, Maryland

Harbor Hospital Center, Baltimore, Maryland

Sinai Hospital of Baltimore, Baltimore, Maryland

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Peninsula Regional Medical Center, Salisbury, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

Cape Cod Hospital, Hyannis, Massachusetts

Veterans Affairs Medical Center - Boston (Jamaica Plain), Jamaica Plain, Massachusetts

CCOP - Ann Arbor Regional, Ann Arbor, Michigan

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan

Henry Ford Hospital, Detroit, Michigan

Hurley Medical Center, Flint, Michigan

McLaren Regional Cancer Center, Flint, Michigan

CCOP - Kalamazoo, Kalamazoo, Michigan

Marquette General Hospital, Marquette, Michigan

MidMichigan Medical Center - Midland, Midland, Michigan

CCOP - Beaumont, Royal Oak, Michigan

William Beaumont Hospital, Royal Oak, Michigan

William Beaumont Hospital - Troy, Troy, Michigan

Mayo Clinic Cancer Center, Rochester, Minnesota

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota

Ellis Fischel Cancer Center - Columbia, Columbia, Missouri

CCOP - Kansas City, Kansas City, Missouri

Mallinckrodt Institute of Radiology, Saint Louis, Missouri

St. Louis University Health Sciences Center, Saint Louis, Missouri

Cancer Research for the Ozarks, Springfield, Missouri

CCOP - Cancer Research for the Ozarks, Springfield, Missouri

CCOP - Montana Cancer Consortium, Billings, Montana

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska

Methodist Hospital Cancer Center - Omaha, Omaha, Nebraska

Nebraska Health System, Omaha, Nebraska

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada

Norris Cotton Cancer Center, Lebanon, New Hampshire

Elliot Regional Cancer Center, Manchester, New Hampshire

Veterans Affairs Medical Center - East Orange, East Orange, New Jersey

John F. Kennedy Medical Center, Edison, New Jersey

Trinitas Hospital - Jersey Street Campus, Elizabeth, New Jersey

Monmouth Medical Center, Long Branch, New Jersey

South Jersey Regional Cancer Center, Millville, New Jersey

Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital, Mount Holly, New Jersey

Cancer Institute of New Jersey, New Brunswick, New Jersey

Newark Beth Israel Medical Center, Newark, New Jersey

Atlantic City Medical Center, Pomona, New Jersey

Valley Hospital, Ridgewood, New Jersey

Community Medical Center, Toms River, New Jersey

St. Francis Medical Center, Trenton, New Jersey

Associated Radiologists, P.A., Warren, New Jersey

Radiation Oncology Associates of Albuquerque, Albuquerque, New Mexico

Cancer Center of Albany Medical Center, Albany, New York

State University of New York Health Science Center at Brooklyn, Brooklyn, New York

New York Methodist Hospital, Brooklyn, New York

Roswell Park Cancer Institute, Buffalo, New York

Finger Lakes Radiation Oncology Center, Clifton Springs, New York

CCOP - North Shore University Hospital, Manhasset, New York

Herbert Irving Comprehensive Cancer Center, New York, New York

Champlain Valley Physicians Hospital Medical Center, Plattsburgh, New York

Vassar Brothers Medical Center, Poughkeepsie, New York

James P. Wilmot Cancer Center, Rochester, New York

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York

Riverhill Radiation Oncology, Yonkers, New York

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina

Northeast Medical Center, Concord, North Carolina

East Carolina University School of Medicine, Greenville, North Carolina

CCOP - Southeast Cancer Control Consortium, Winston-Salem, North Carolina

Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina

Trinity Cancer Care Center, Minot, North Dakota

Akron General Medical Center, Akron, Ohio

Akron City Hospital, Akron, Ohio

Christ Hospital, Cincinnati, Ohio

Barrett Cancer Center, Cincinnati, Ohio

Ireland Cancer Center, Cleveland, Ohio

University Hospitals of Cleveland, Cleveland, Ohio

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio

CCOP - Columbus, Columbus, Ohio

Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio

CCOP - Dayton, Dayton, Ohio

CCOP - Toledo Community Hospital, Toledo, Ohio

St. Anthony Hospital, Oklahoma City, Oklahoma

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

St. John Health System, Tulsa, Oklahoma

CCOP - Oklahoma, Tulsa, Oklahoma

CCOP - Columbia River Program, Portland, Oregon

Lehigh Valley Hospital, Allentown, Pennsylvania

St. Luke's Hospital Cancer Center, Bethlehem, Pennsylvania

Geisinger Medical Center, Danville, Pennsylvania

Mercy Fitzgerald Hospital, Darby, Pennsylvania

Delaware County Memorial Hospital, Drexel Hill, Pennsylvania

Pocono Cancer Center, East Stroudsburg, Pennsylvania

Milton S. Hershey Medical Center, Hershey, Pennsylvania

University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania

Veterans Affairs Medical Center - Philadelphia, Philadelphia, Pennsylvania

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Albert Einstein Cancer Center, Philadelphia, Pennsylvania

University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

Mercy Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Western Pennsylvania Hospital, Pittsburgh, Pennsylvania

Reading Hospital and Medical Center, Reading, Pennsylvania

Mercy Hospital Cancer Center - Scranton, Scranton, Pennsylvania

Wilkes Barre General Hospital, Wilkes-Barre, Pennsylvania

York Cancer Center, York, Pennsylvania

Roger Williams Medical Center/BUSM, Providence, Rhode Island

CCOP - Greenville, Greenville, South Carolina

CCOP - Upstate Carolina, Spartanburg, South Carolina

Rapid City Regional Hospital, Rapid City, South Dakota

Jackson-Madison County General Hospital, Jackson, Tennessee

University of Tennessee Cancer Institute, Memphis, Tennessee

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee

Harrington Cancer Center, Amarillo, Texas

University of Texas Medical Branch, Galveston, Texas

University of Texas - MD Anderson Cancer Center, Houston, Texas

Wilford Hall Medical Center, Lackland Air Force Base, Texas

Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas

Bayshore Medical Center, Pasadena, Texas

Dixie Regional Medical Center, Saint George, Utah

University of Utah Health Sciences Center, Salt Lake City, Utah

Latter Day Saints Hospital, Salt Lake City, Utah

Vermont Cancer Center, Burlington, Vermont

Cancer Center at the University of Virginia, Charlottesville, Virginia

RMH Regional Cancer Center, Harrisonburg, Virginia

Naval Medical Center, Portsmouth, Portsmouth, Virginia

Bon Secours - St. Mary's Hospital, Richmond, Virginia

Massey Cancer Center, Richmond, Virginia

Virginia Mason Medical Center, Seattle, Washington

Deaconess Medical Center, Spokane, Washington

Yakima Valley Memorial Hospital, Yakima, Washington

Schiffler Cancer Center, Wheeling, West Virginia

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin

St. Vincent Hospital, Green Bay, Wisconsin

Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin

Southern Wisconsin Radiotherapy Center, Madison, Wisconsin

University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin

Marshfield Clinic, Marshfield, Wisconsin

Community Memorial Hospital, Menomonee Falls, Wisconsin

Columbia Hospital, Milwaukee, Wisconsin

St. Luke's Medical Center, Milwaukee, Wisconsin

Medical College of Wisconsin, Milwaukee, Wisconsin

Veterans Affairs Medical Center - Milwaukee (Zablocki), Milwaukee, Wisconsin

All Saints Cancer Center, Racine, Wisconsin

Waukesha Memorial Hospital, Waukesha, Wisconsin

Tom Baker Cancer Center - Calgary, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

Saint John Regional Hospital, Saint John, New Brunswick

Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador

Nova Scotia Cancer Centre, Halifax, Nova Scotia

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario

Kingston Regional Cancer Centre, Kingston, Ontario

Cancer Care Ontario-London Regional Cancer Centre, London, Ontario

Ottawa Regional Cancer Centre, Ottawa, Ontario

Northeastern Ontario Regional Cancer Centre, Sudbury, Sudbury, Ontario

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario

Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario

Princess Margaret Hospital, Toronto, Ontario

CHUS-Hopital Fleurimont, Fleurimont, Quebec

Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec

McGill University, Montreal, Quebec

Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec

Allan Blair Cancer Centre, Regina, Saskatchewan

Saskatoon Cancer Centre, Saskatoon, Saskatchewan

Conditions: Head and Neck Cancer

Learn More ›

Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery

NCT00011960

Completed

RATIONALE: Drugs used in chemotherapy such as cisplatin and paclitaxel use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Cisplatin and paclitaxel may make the tumor cells more sensitive to radiation therapy and may kill any tumor cells remaining after surgery. PURPOSE: Randomized phase II trial to study the effectiveness of cisplatin, paclitaxel, and radiation therapy with or without fluorouracil in... Read More

Gender:

ALL

Ages:

All

Trial Updated:

11/14/2015

Locations: University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama +68 locations

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama

Mobile Infirmary Medical Center, Mobile, Alabama

Providence Alaska Medical Center, Anchorage, Alaska

Foundation for Cancer Research and Education, Phoenix, Arizona

Providence Saint Joseph Medical Center - Burbank, Burbank, California

City of Hope Comprehensive Cancer Center, Duarte, California

Sutter Health Western Division Cancer Research Group, Greenbrae, California

Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California

CCOP - Bay Area Tumor Institute, Oakland, California

University of California Davis Cancer Center, Sacramento, California

CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California

Memorial Hospital Cancer Center, Colorado Springs, Colorado

University of Colorado Cancer Center at University of Colorado Health Sciences Center, Denver, Colorado

Yale Comprehensive Cancer Center, New Haven, Connecticut

Baptist Hospital of Miami, Miami, Florida

Alexian Brothers Cancer Care Center, Elk Grove Village, Illinois

Wendt Regional Cancer Center of Finley Hospital, Dubuque, Iowa

Cancer Center at Lexington Clinic, Lexington, Kentucky

Cancer Research Center at Boston Medical Center, Boston, Massachusetts

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota

CCOP - Kansas City, Kansas City, Missouri

Siteman Cancer Center, Saint Louis, Missouri

Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha, Omaha, Nebraska

John F. Kennedy Medical Center, Edison, New Jersey

Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital, Mount Holly, New Jersey

Community Medical Center, Toms River, New Jersey

New York Methodist Hospital, Brooklyn, New York

Highland Hospital of Rochester, Rochester, New York

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse, New York

Wayne Memorial Hospital, Inc., Goldsboro, North Carolina

Rutherford Hospital, Rutherfordton, North Carolina

Akron General Medical Center, Akron, Ohio

Akron City Hospital - Summa Health System, Akron, Ohio

Ireland Cancer Center, Cleveland, Ohio

CCOP - Dayton, Dayton, Ohio

Blanchard Valley Medical Associates, Findlay, Ohio

Lima Memorial Hospital, Lima, Ohio

St. Charles Hospital, Oregon, Ohio

Cancer Care Center, Incorporated, Salem, Ohio

Firelands Regional Medical Center, Sandusky, Ohio

Flower Hospital - ProMedica Health System, Sylvania, Ohio

Medical College of Ohio Cancer Institute, Toledo, Ohio

CCOP - Toledo Community Hospital, Toledo, Ohio

Fulton County Health Center, Wauseon, Ohio

Natalie Warren Bryant Cancer Center, Tulsa, Oklahoma

John and Dorothy Morgan Cancer Center at Lehigh Valley Hospital, Allentown, Pennsylvania

Bryn Mawr Hospital, Bryn Mawr, Pennsylvania

Mercy Fitzgerald Hospital, Darby, Pennsylvania

Delaware County Memorial Hospital, Drexel Hill, Pennsylvania

Pocono Cancer Center, East Stroudsburg, Pennsylvania

Paoli Memorial Hospital, Paoli, Pennsylvania

Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania

Western Pennsylvania Hospital, Pittsburgh, Pennsylvania

Lankenau Cancer Center at Lankenau Hospital, Wynnewood, Pennsylvania

CCOP - Upstate Carolina, Spartanburg, South Carolina

University of Texas - MD Anderson Cancer Center, Houston, Texas

Cottonwood Hospital Medical Center, Murray, Utah

McKay-Dee Hospital Center, Ogden, Utah

Dixie Regional Medical Center, Saint George, Utah

University of Utah Health Sciences Center, Salt Lake City, Utah

LDS Hospital, Salt Lake City, Utah

University of Washington Medical Center, Seattle, Washington

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay, Wisconsin

St. Vincent Hospital, Green Bay, Wisconsin

CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin

Columbia Hospital, Milwaukee, Wisconsin

St. Luke's Medical Center, Milwaukee, Wisconsin

Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin

Conditions: Esophageal Cancer, Gastric Cancer

Learn More ›

Browse by State

Paclitaxel treatment options in Alabama

Paclitaxel treatment options in Alaska

Paclitaxel treatment options in Arizona

Paclitaxel treatment options in Arkansas

Paclitaxel treatment options in California

Paclitaxel treatment options in Colorado

Paclitaxel treatment options in Connecticut

Paclitaxel treatment options in Delaware

Paclitaxel treatment options in District of Columbia

Paclitaxel treatment options in Florida

Paclitaxel treatment options in Georgia

Paclitaxel treatment options in Hawaii

Paclitaxel treatment options in Idaho

Paclitaxel treatment options in Illinois

Paclitaxel treatment options in Indiana

Paclitaxel treatment options in Iowa

Paclitaxel treatment options in Kansas

Paclitaxel treatment options in Kentucky

Paclitaxel treatment options in Louisiana

Paclitaxel treatment options in Maine

Paclitaxel treatment options in Montana

Paclitaxel treatment options in Nebraska

Paclitaxel treatment options in Nevada

Paclitaxel treatment options in New Hampshire

Paclitaxel treatment options in New Jersey

Paclitaxel treatment options in New Mexico

Paclitaxel treatment options in New York

Paclitaxel treatment options in North Carolina

Paclitaxel treatment options in North Dakota

Paclitaxel treatment options in Ohio

Paclitaxel treatment options in Oklahoma

Paclitaxel treatment options in Oregon

Paclitaxel treatment options in Maryland

Paclitaxel treatment options in Massachusetts

Paclitaxel treatment options in Michigan

Paclitaxel treatment options in Minnesota

Paclitaxel treatment options in Mississippi

Paclitaxel treatment options in Missouri

Paclitaxel treatment options in Pennsylvania

Paclitaxel treatment options in Rhode Island

Paclitaxel treatment options in South Carolina

Paclitaxel treatment options in South Dakota

Paclitaxel treatment options in Tennessee

Paclitaxel treatment options in Texas

Paclitaxel treatment options in Utah

Paclitaxel treatment options in Vermont

Paclitaxel treatment options in Virginia

Paclitaxel treatment options in Washington

Paclitaxel treatment options in West Virginia

Paclitaxel treatment options in Wisconsin

Paclitaxel treatment options in Wyoming